Invention Grant
- Patent Title: Modulatable switch for selection of donor modified cells
-
Application No.: US16538818Application Date: 2019-08-12
-
Publication No.: US11213548B2Publication Date: 2022-01-04
- Inventor: Christopher Walter Alma , Jeffrey Bartlett , Louis Randall Breton , Geoffrey Phillip Symonds , Ming Yan
- Applicant: CSL Behring Gene Therapy, Inc. , CSL Gene Therapy Pty Ltd.
- Applicant Address: US CA Pasadena; AU Parkville
- Assignee: CSL Behring Gene Therapy, Inc.,CSL Gene Therapy Pty Ltd.
- Current Assignee: CSL Behring Gene Therapy, Inc.,CSL Gene Therapy Pty Ltd.
- Current Assignee Address: US CA Pasadena; AU Parkville
- Agency: Charney IP Law LLC
- Agent Thomas M. Finetti
- Main IPC: A61K35/17
- IPC: A61K35/17 ; A61K35/28 ; A61P37/06 ; A61P35/02 ; C12N5/0783 ; A61K35/12 ; A61K31/52
Abstract:
The disclosed methods are generally directed to preventing, treating, suppressing, controlling or otherwise mitigating side effects of T-cell therapy, the T-cell therapy designed to accelerate immune reconstitution, induce a GVM effect, and/or target tumor cells.
Public/Granted literature
- US20200038444A1 MODULATABLE SWITCH FOR SELECTION OF DONOR MODIFIED CELLS Public/Granted day:2020-02-06
Information query
IPC分类:
